USAIC’s 18th annual BioPharma & Healthcare Summit

Apr 25, 2024

The Newbury Boston Hotel

Posted by Takeda

Register Offsite
Add to Calendar + 2024-04-25 8:00 2024-04-25 18:00 America/New_York USAIC’s 18th annual BioPharma & Healthcare Summit

Meet & network with top global BioPharma leaders, VCs, and senior Academic colleagues at USAIC’s 18th annual BioPharma & Healthcare Summit

Chair & Emcee: Dr. Mathai Mammen, Chairman & CEO, FogPharma
Super Session: Honoring Dr. Andrew Plump, President of R&D, Takeda with the Distinguished Service Award (4th award in 18 years)

Some of the Participants & Speakers

Chris Viehbacher, CEO, Biogen; Tony Wood, CSO, GSK; Marcus Schindler, CSO, Novo Nordisk; Robert Plenge, Head of Research, BMS; Stelios Papadopoulos, Chair of the Board, Exelixis; Narimon Honarpour, SVP Global Development, Amgen; Elias Zerhouni, Vice Chairman, OPKO Health; Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group; Marc Tessier-Lavigne, Stanford University; Daphne Zohar, Founder & CEO, PureTech Health; Dina Katabi, Professor of Computer Science, MIT; Jeb Keiper, CEO, Nimbus Therapeutics; Sastry Chilukuri, Chairman, Emmes Group; Martin Mackay, Co-Founder, Rallybio; Sam Waksal, CEO, Graviton Biosciences; Najat Khan, Chief Data Science Officer, Janssen R&D; David Meeker, CEO,  Rhythm; Michael Rosenblatt, Senior Advisor, Bain, Flagship; Badhri Srinivasan, Head, Global Clinical Operations, Novartis; Uli Broedl, Head of Global Clinical Dev, Boehringer Ingelheim; Philip Larsen, CEO, Six Peaks Bio; Timothy Yu, Boston Children’s Hospital;  Alexandria Forbes, CEO, MeiraGTx; Adams Jan, Chief Scientific Officer, Grünenthal; Tsutomu Une, Board Member, Ayumi Pharmaceutical Holdings; Patrick Anquetil, CEO, Portal Instruments

Networking Tea Breaks, Hosted Lunch, Cocktails & Networking Reception

Panel Discussions and Fireside Chats Covering

Oncology

Rare Diseases

Value & Access

Future Pandemics

R&D Strategies and Trends

Industry Academic Partnerships

Clinical Trials Opportunities in India

Digital & Data Science in Healthcare

BioPharma Industry & Investment Outlook


Strategy Sessions (by invitation only):

External Research & Clinical Trials Opportunities in India

Digital & Data Sciences

Register online at www.usaindiachamber.org
Limited Seats. Registration rates will go up soon

USAIC
Tel: 781 586-1212
info@usaindiachamber.org
#USAIC24

The Newbury Boston Hotel, Boston, MA, 1 Newbury Street

Meet & network with top global BioPharma leaders, VCs, and senior Academic colleagues at USAIC’s 18th annual BioPharma & Healthcare Summit

Chair & Emcee: Dr. Mathai Mammen, Chairman & CEO, FogPharma
Super Session: Honoring Dr. Andrew Plump, President of R&D, Takeda with the Distinguished Service Award (4th award in 18 years)

Some of the Participants & Speakers

Chris Viehbacher, CEO, Biogen; Tony Wood, CSO, GSK; Marcus Schindler, CSO, Novo Nordisk; Robert Plenge, Head of Research, BMS; Stelios Papadopoulos, Chair of the Board, Exelixis; Narimon Honarpour, SVP Global Development, Amgen; Elias Zerhouni, Vice Chairman, OPKO Health; Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group; Marc Tessier-Lavigne, Stanford University; Daphne Zohar, Founder & CEO, PureTech Health; Dina Katabi, Professor of Computer Science, MIT; Jeb Keiper, CEO, Nimbus Therapeutics; Sastry Chilukuri, Chairman, Emmes Group; Martin Mackay, Co-Founder, Rallybio; Sam Waksal, CEO, Graviton Biosciences; Najat Khan, Chief Data Science Officer, Janssen R&D; David Meeker, CEO,  Rhythm; Michael Rosenblatt, Senior Advisor, Bain, Flagship; Badhri Srinivasan, Head, Global Clinical Operations, Novartis; Uli Broedl, Head of Global Clinical Dev, Boehringer Ingelheim; Philip Larsen, CEO, Six Peaks Bio; Timothy Yu, Boston Children’s Hospital;  Alexandria Forbes, CEO, MeiraGTx; Adams Jan, Chief Scientific Officer, Grünenthal; Tsutomu Une, Board Member, Ayumi Pharmaceutical Holdings; Patrick Anquetil, CEO, Portal Instruments

Networking Tea Breaks, Hosted Lunch, Cocktails & Networking Reception

Panel Discussions and Fireside Chats Covering

Oncology

Rare Diseases

Value & Access

Future Pandemics

R&D Strategies and Trends

Industry Academic Partnerships

Clinical Trials Opportunities in India

Digital & Data Science in Healthcare

BioPharma Industry & Investment Outlook


Strategy Sessions (by invitation only):

External Research & Clinical Trials Opportunities in India

Digital & Data Sciences

Register online at www.usaindiachamber.org
Limited Seats. Registration rates will go up soon

USAIC
Tel: 781 586-1212
info@usaindiachamber.org
#USAIC24

See all Member Events